IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 25 filers reported holding IMMUNOVANT INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,164,634 | -68.5% | 110,183 | -52.1% | 0.08% | -71.9% |
| Q1 2021 | $3,692,135 | +1136.2% | 230,183 | +1776.6% | 0.28% | +578.0% |
| Q2 2020 | $298,677 | -75.0% | 12,266 | -84.0% | 0.04% | -86.2% |
| Q1 2020 | $1,196,419 | -1.9% | 76,866 | 0.0% | 0.30% | +38.1% |
| Q4 2019 | $1,219,863 | – | 76,866 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
| Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
| Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
| Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
| FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
| MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
| EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
| MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |